SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-160964
Filing Date
2022-05-26
Accepted
2022-05-26 16:02:08
Documents
12
Period of Report
2022-05-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d353637d8k.htm   iXBRL 8-K 29481
  Complete submission text file 0001193125-22-160964.txt   151326

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rapt-20220525.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapt-20220525_lab.xml EX-101.LAB 17979
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapt-20220525_pre.xml EX-101.PRE 11253
6 EXTRACTED XBRL INSTANCE DOCUMENT d353637d8k_htm.xml XML 3355
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 22969842
SIC: 2834 Pharmaceutical Preparations